Nuformix (LON:NFX) Stock Price Down 12.5%

Nuformix plc (LON:NFX)’s stock price fell 12.5% during trading on Wednesday . The stock traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.06 ($0.00). 19,272,414 shares traded hands during mid-day trading, an increase of 383% from the average session volume of 3,989,162 shares. The stock had previously closed at GBX 0.06 ($0.00).

Nuformix Trading Up 1.6 %

The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 3.35. The stock has a market cap of £507,972.20, a P/E ratio of -1.63 and a beta of 1.22. The firm’s fifty day moving average price is GBX 0.16 and its two-hundred day moving average price is GBX 0.18.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.